Pfizer to acquire oncology specialist Medivation for $ 14 bn
American global pharmaceutical major Pfizer Inc has entered into an agreement to acquire Medivation Inc, a biopharmaceutical company focused on developing and commercialising small molecules for oncology, for a total enterprise value of approximately $ 14 billion.
The merger will give a boost to Pfizer’s consolidation effort through a series of acquisitions, especially after its bid to take over Allergan Plc in a $150 billion deal late last year fell apart when the Obama administration prevented the proposed combination with new rules.
So let's do:
1. Pfizer to acquire oncology specialist Medivation for ____.